Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShahmardanova, S. A.-
dc.contributor.authorGulevskaya, O. N.-
dc.contributor.authorGalenko-Yaroshevsky, P. A.-
dc.contributor.authorKolesnichenko, P. D.-
dc.identifier.citationDevelopment perspectives of new generation medications based on the redox system regulators / S. A. Shahmardanova [и др.] // Research result: pharmacology and clinical pharmacology. - 2016. - Т.2, №4.- С. 95-102. - DOI: 10.184 13/2500-235X-2016-2-4-95-102. - Refer.: p.
dc.description.abstractThis survey paper describes the necessity of the development of new medications influencing the body redox-potential. It supports the most pressing branch of pharmacology, which coincides with logically relevant attempts to shift paradigm of pharmacology from molecular to electronic, quantum-wave. This article covers and logically assorts research results of recent years and opinions of wide range of scientists from various countries. The authors also give their own assessment of the possibility to influence body redox potential. It is reported that some biophysical achievements regarded undoubtedly put a new spin in pharmacology of the biophysical levelru
dc.subjectreactive oxygen speciesru
dc.subjectreduction-oxidation reactionsru
dc.subjectredox potentialru
dc.titleDevelopment perspectives of new generation medications based on the redox system regulatorsru
Appears in Collections:Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)

Files in This Item:
File Description SizeFormat 
Shahmardanova_ Development_16.pdf701 kBAdobe PDFView/Open
Show simple item record

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.